TipRanks
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
Germany Market
17Q1
Pharmaron Beijing Co., Ltd. Class H
RESEARCH TOOLSreports

Pharmaron Beijing Co., Ltd. Class H (17Q1) Ratios

0 Followers

Pharmaron Beijing Co., Ltd. Class H Ratios

DE:17Q1's free cash flow for Q2 2026 was ¥0.31. For the 2026 fiscal year, DE:17Q1's free cash flow was decreased by ¥ and operating cash flow was ¥0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.02 0.93 1.80 2.98 1.67
Quick Ratio
 0.80 0.75 1.54 2.70 1.40
Cash Ratio
 0.18 0.12 0.40 1.62 0.38
Solvency Ratio
 0.24 0.25 0.29 0.19 0.21
Operating Cash Flow Ratio
 0.34 0.39 0.61 0.75 0.55
Short-Term Operating Cash Flow Coverage
 0.63 2.55 3.37 4.77 3.23
Net Current Asset Value
¥ -3.03B¥ -3.58B¥ -2.10B¥ -2.36B¥ -3.12B
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.13 0.23 0.35 0.30
Debt-to-Equity Ratio
 0.43 0.23 0.41 0.75 0.58
Debt-to-Capital Ratio
 0.30 0.18 0.29 0.43 0.37
Long-Term Debt-to-Capital Ratio
 0.11 0.11 0.24 0.40 0.30
Financial Leverage Ratio
 1.77 1.80 1.76 2.11 1.94
Debt Service Coverage Ratio
 0.61 2.01 2.98 3.54 2.67
Interest Coverage Ratio
 10.32 10.00 8.63 10.14 10.10
Debt to Market Cap
 0.10 0.10 0.22 0.35 0.09
Interest Debt Per Share
 3.89 2.05 3.24 5.38 3.54
Net Debt to EBITDA
 1.58 0.73 1.14 1.17 1.83
Profitability Margins
Gross Profit Margin
33.27%34.83%34.24%35.75%36.71%
EBIT Margin
14.53%14.94%19.02%17.51%17.86%
EBITDA Margin
22.39%23.32%27.56%25.54%24.64%
Operating Profit Margin
13.49%13.68%17.14%16.02%16.46%
Pretax Profit Margin
13.34%13.57%17.04%15.93%16.23%
Net Profit Margin
11.27%11.80%14.61%13.88%13.39%
Continuous Operations Profit Margin
10.62%11.03%13.96%13.71%13.17%
Net Income Per EBT
84.53%86.99%85.75%87.12%82.49%
EBT Per EBIT
98.83%99.18%99.37%99.46%98.61%
Return on Assets (ROA)
5.92%6.14%7.49%6.05%6.71%
Return on Equity (ROE)
10.96%11.05%13.17%12.75%13.03%
Return on Capital Employed (ROCE)
10.14%10.30%10.68%8.10%10.19%
Return on Invested Capital (ROIC)
6.56%7.84%8.43%6.80%7.95%
Return on Tangible Assets
7.09%7.46%8.80%6.99%8.08%
Earnings Yield
2.07%5.37%7.58%6.30%2.43%
Efficiency Ratios
Receivables Turnover
 5.11 4.31 4.05 4.38 4.64
Payables Turnover
 13.32 15.14 16.92 17.98 15.99
Inventory Turnover
 5.24 6.24 7.23 7.32 6.24
Fixed Asset Turnover
 1.26 1.19 1.16 1.16 1.24
Asset Turnover
 0.52 0.52 0.51 0.44 0.50
Working Capital Turnover Ratio
 36.72 10.07 2.32 2.34 2.48
Cash Conversion Cycle
 113.61 119.18 119.01 112.98 114.41
Days of Sales Outstanding
 71.37 84.77 90.10 83.40 78.73
Days of Inventory Outstanding
 69.65 58.50 50.49 49.88 58.50
Days of Payables Outstanding
 27.41 24.10 21.57 20.30 22.83
Operating Cycle
 141.02 143.28 140.58 133.28 137.23
Cash Flow Ratios
Operating Cash Flow Per Share
 1.59 1.83 1.44 1.55 1.21
Free Cash Flow Per Share
 0.02 0.31 0.30 -0.06 -0.46
CapEx Per Share
 1.57 1.51 1.14 1.62 1.66
Free Cash Flow to Operating Cash Flow
 0.02 0.17 0.21 -0.04 -0.38
Dividend Paid and CapEx Coverage Ratio
 0.85 1.01 1.00 0.83 0.64
Capital Expenditure Coverage Ratio
 1.02 1.21 1.26 0.96 0.73
Operating Cash Flow Coverage Ratio
 0.42 0.94 0.46 0.29 0.35
Operating Cash Flow to Sales Ratio
 0.19 0.23 0.21 0.24 0.21
Free Cash Flow Yield
0.07%1.78%2.26%-0.44%-1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 46.36 18.72 13.11 15.87 41.12
Price-to-Sales (P/S) Ratio
 4.37 2.20 1.93 2.20 5.51
Price-to-Book (P/B) Ratio
 5.05 2.06 1.74 2.02 5.36
Price-to-Free Cash Flow (P/FCF) Ratio
 1.48K 56.17 44.16 -227.29 -70.03
Price-to-Operating Cash Flow Ratio
 28.22 9.63 9.19 9.23 26.38
Price-to-Earnings Growth (PEG) Ratio
 1.78 -2.70 13.11 1.43 -2.09
Price-to-Fair Value
 5.05 2.06 1.74 2.02 5.36
Enterprise Value Multiple
 21.11 10.16 8.13 9.79 24.17
Enterprise Value
 71.81B 33.40B 27.52B 28.85B 61.14B
EV to EBITDA
 21.11 10.16 8.13 9.79 24.17
EV to Sales
 4.73 2.37 2.24 2.50 5.96
EV to Free Cash Flow
 1.59K 60.52 51.35 -258.09 -75.75
EV to Operating Cash Flow
 24.52 10.37 10.68 10.48 28.53
Tangible Book Value Per Share
 6.68 6.22 5.97 5.45 4.15
Shareholders’ Equity Per Share
 8.90 8.55 7.62 7.08 5.95
Tax and Other Ratios
Effective Tax Rate
 0.20 0.19 0.18 0.14 0.19
Revenue Per Share
 8.27 8.00 6.87 6.51 5.79
Net Income Per Share
 0.93 0.94 1.00 0.90 0.78
Tax Burden
 0.85 0.87 0.86 0.87 0.82
Interest Burden
 0.92 0.91 0.90 0.91 0.91
Research & Development to Revenue
 0.04 0.04 0.04 0.04 0.03
SG&A to Revenue
 0.10 0.06 0.06 0.14 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.02
Income Quality
 1.71 2.07 1.50 1.74 1.58
Currency in CNY